Search This Blog

Wednesday, August 7, 2019

Intra-Cellular Therapies EPS beats by $0.17

Intra-Cellular Therapies (NASDAQ:ITCI): Q2 GAAP EPS of -$0.68 beats by $0.17.
Cash and equivalents of $91.76M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)